Overall Survival In Myelodysplastic Syndrome or Acute Myeloid Leukemia Patients Treated with On 01910.Na Correlates with Bone Marrow Blast Response.

被引：0
|
作者：
Silverman, Lewis R. [1 ]
Kaza, Azra [2 ]
Sloand, Elaine M. [3 ]
Greenberg, Peter L. [4 ]
Wilhelm, Frandois E. [5 ]
机构：
[1] Mt Sinai Sch Med, Div Hematol Oncol, New York, NY USA
[2] St Vincents Comprehens Canc Ctr, New York, NY USA
[3] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
[4] Stanford Univ, Div Hematol, Stanford Canc Ctr, Stanford, CA 94305 USA
[5] Onconova Therapeut Inc, Newtown, PA USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1629 / 1630
页数：2
相关论文
共 50 条
  • [11] Genetic and epigenetic alterations of bone marrow stromal cells in myelodysplastic syndrome and acute myeloid leukemia patients
    Kim, Yonggoo
    Jekarl, Dong Wook
    Kim, Jiyeon
    Kwon, Ahlm
    Choi, Hayoung
    Lee, Seungok
    Kim, Yoo-Jin
    Kim, Hee-Je
    Kim, Yonghwan
    Oh, Il-Hoan
    Kim, Myungshin
    STEM CELL RESEARCH, 2015, 14 (02) : 177 - 184
  • [12] Highly variable Separase activity patterns in bone marrow of patients with myelodysplastic syndrome and acute myeloid leukemia
    Ruppenthal, S.
    Prinzhorn, W.
    Kleiner, H.
    Lammer, F.
    Nowak, D.
    Hofmann, W-K
    Fabarius, A.
    Seifarth, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 59 - 59
  • [13] Selective Blast Cell Reduction in Elderly Patients with Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome Treated with Methylprednisolone
    Kei Suzuki
    Kohshi Ohishi
    Takao Sekine
    Masahiro Masuya
    Naoyuki Katayama
    International Journal of Hematology, 2007, 85 : 344 - 349
  • [14] Blast cell reduction in elderly patients with acute myeloid leukemia secondary to myelodysplastic syndrome treated with methylprednisolone.
    Suzuki, Kei
    Sekine, Takao
    Ohishi, Kohshi
    Katayama, Naoyuki
    BLOOD, 2006, 108 (11) : 294B - 294B
  • [15] Selective blast cell reduction in elderly patients with acute myeloid leukemia secondary to Myelodysplastic syndrome treated with methylprednisolone
    Suzuki, Kei
    Ohishi, Kohshi
    Sekine, Takao
    Masuya, Masahiro
    Katayama, Naoyuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 85 (04) : 344 - 349
  • [16] AZACITIDINE (AZA) IMPROVES OVERALL SURVIVAL (OS) IN WHO ACUTE MYELOID LEUKEMIA (AML) IN ELDERLY PATIENTS WITH LOW BONE MARROW BLAST COUNTS
    Fenaux, P. F.
    Silverman, L. R.
    Mufti, G. J.
    Hellstrom-Lindberg, E.
    Santini, V.
    Gattermann, N.
    Sanz, G.
    Seymour, J. F.
    Gore, S. D.
    Dombret, H.
    McKenzie, D.
    Backstrom, J.
    Beach, C. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 430 - 431
  • [17] Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
    Fenaux, Pierre
    Mufti, Ghulam J.
    Hellstrom-Lindberg, Eva
    Santini, Valeria
    Gattermann, Norbert
    Germing, Ulrich
    Sanz, Guillermo
    List, Alan F.
    Gore, Steven
    Seymour, John F.
    Dombret, Herve
    Backstrom, Jay
    Zimmerman, Linda
    McKenzie, David
    Beach, C. L.
    Silverman, Lewis R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) : 562 - 569
  • [18] Early myelodysplastic syndrome after allogeneic bone marrow transplantation for acute myeloid leukemia
    Muroi, K
    Kawano, C
    Yokote, T
    Otsuki, T
    Kirito, K
    Komatsu, N
    Ozawa, K
    LEUKEMIA & LYMPHOMA, 2002, 43 (07) : 1493 - 1496
  • [19] Using karnofsky performance status (KPS) of bone marrow transplant (BMT) patients at time of transplant as a predictor of overall survival of patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Privitere, Lisa
    Syta, Margaret
    ONCOLOGY NURSING FORUM, 2007, 34 (02) : 562 - 563
  • [20] MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH FLUDARABINE
    Colovic, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 506 - 506
12345